These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28385415)

  • 21. Bioresorbable Scaffolds for the Management of Coronary Bifurcation Lesions.
    Kawamoto H; Ruparelia N; Tanaka A; Chieffo A; Latib A; Colombo A
    JACC Cardiovasc Interv; 2016 May; 9(10):989-1000. PubMed ID: 27198679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes following target lesion revascularization for bioresorbable scaffold failure.
    Tanaka A; Ruparelia N; Kawamoto H; Sticchi A; Figini F; Carlino M; Chieffo A; Montorfano M; Latib A; Colombo A
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):832-6. PubMed ID: 26331577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry.
    Hoppmann P; Kufner S; Cassese S; Wiebe J; Schneider S; Pinieck S; Scheler L; Bernlochner I; Joner M; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):822-9. PubMed ID: 26708019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fracture with the newer bioresorbable vascular scaffolds.
    Elwany M; Di Palma G; Cortese B
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):582-583. PubMed ID: 28295999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioresorbable vascular scaffold implantation for recurrent in-stent restenosis: an option in case of multiple failures?
    Ielasi A; Saino A; Silvestro A; Personeni D; Tespili M
    EuroIntervention; 2014 Jul; 10(3):337. PubMed ID: 24647134
    [No Abstract]   [Full Text] [Related]  

  • 26. Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: 1-Year Results From the ABSORB III Trial.
    Baron SJ; Lei Y; Chinnakondepalli K; Vilain K; Magnuson EA; Kereiakes DJ; Ellis SG; Stone GW; Cohen DJ;
    JACC Cardiovasc Interv; 2017 Apr; 10(8):774-782. PubMed ID: 28427593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
    Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds: A Review of the Published Data, Practical Recommendations, and Future Directions.
    Capodanno D; Angiolillo DJ
    JACC Cardiovasc Interv; 2017 Mar; 10(5):425-437. PubMed ID: 28279311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fate of Bioresorbable Vascular Scaffold Metallic Radio-Opaque Markers at the Site of Implantation After Bioresorption.
    Suwannasom P; Onuma Y; Campos CM; Nakatani S; Ishibashi Y; Tateishi H; Grundeken MJ; Stanetic B; Nieman K; Jonker H; Garcia-Garcia HM; Serruys PW;
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1130-1132. PubMed ID: 26205450
    [No Abstract]   [Full Text] [Related]  

  • 30. Mid- to long-term outcome of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Data of the BVS registry Göttingen predominantly from ACS patients.
    Hellenkamp K; Becker A; Gabriel YD; Hasenfuß G; Hünlich M; Jacobshagen C; Schillinger W; Schroeter MR
    Int J Cardiol; 2017 May; 234():58-63. PubMed ID: 28258843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Full Plastic-Jacket": Reconstruction of 18 cm of coronary arteries with bioresorbable vascular scaffolds in a young patient with ST-elevation myocardial infarction and multivessel disease.
    Denegri A; Frangieh AH; D'Ascenzo F; Ghadri JR; Nietlispach F; Templin C
    Cardiol J; 2017; 24(2):221-223. PubMed ID: 28421591
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of Strut Width in Periprocedural Myocardial Infarction: A Propensity-Matched Comparison Between Bioresorbable Scaffolds and the First-Generation Sirolimus-Eluting Stent.
    Kawamoto H; Panoulas VF; Sato K; Miyazaki T; Naganuma T; Sticchi A; Figini F; Latib A; Chieffo A; Carlino M; Montorfano M; Colombo A
    JACC Cardiovasc Interv; 2015 Jun; 8(7):900-9. PubMed ID: 26003020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early neoatherosclerosis after bioresorbable vascular scaffold implantation: insights from optical coherence tomography.
    Sato T; Richardt G; Abdel-Wahab M
    Coron Artery Dis; 2016 Nov; 27(7):616-7. PubMed ID: 27228185
    [No Abstract]   [Full Text] [Related]  

  • 34. Very Late Restenosis After Bioresorbable Scaffold Implantation Due to Simultaneous External Compression of the Scaffold and Intrascaffold Tissue Growth.
    Tanaka A; Ruparelia N; Kawamoto H; Latib A; Colombo A
    JACC Cardiovasc Interv; 2016 Jan; 9(2):e15-7. PubMed ID: 26723762
    [No Abstract]   [Full Text] [Related]  

  • 35. 'Full polymeric jacket' with bioresorbable vascular scaffolds in a diabetic patient affected by multivessel coronary disease: 1-year optical coherence tomography follow-up.
    Tarantini G; D'Amico G; Isabella G
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e105-e106. PubMed ID: 26090914
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of the learning curve on procedural results and acute outcome after percutaneous coronary interventions with everolimus-eluting bioresorbable scaffolds in an all-comers population.
    Wiebe J; Liebetrau C; Dörr O; Wilkens E; Bauer T; Elsässer A; Achenbach S; Möllmann H; Hamm CW; Nef HM
    Cardiovasc Revasc Med; 2015 Dec; 16(8):455-60. PubMed ID: 26428450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary artery aneurysm after sequential stenting with bioresorbable vascular scaffolds.
    Paradies V; Smits PC
    Coron Artery Dis; 2017 May; 28(3):263-265. PubMed ID: 27845999
    [No Abstract]   [Full Text] [Related]  

  • 38. Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions.
    Abizaid A; Costa RA; Schofer J; Ormiston J; Maeng M; Witzenbichler B; Botelho RV; Costa JR; Chamié D; Abizaid AS; Castro JP; Morrison L; Toyloy S; Bhat V; Yan J; Verheye S
    JACC Cardiovasc Interv; 2016 Mar; 9(6):565-74. PubMed ID: 27013155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome of bioresorbable vascular scaffolds for the treatment of coronary artery disease: a meta-analysis of RCTs.
    Polimeni A; Anadol R; Münzel T; Indolfi C; De Rosa S; Gori T
    BMC Cardiovasc Disord; 2017 Jun; 17(1):147. PubMed ID: 28592227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease.
    Chieffo A; Tanaka A; Giustino G; Briede I; Sawaya FJ; Daemen J; Kawamoto H; Meliga E; D'Ascenzo F; Cerrato E; Stefanini GG; Capodanno D; Mangiameli A; Templin C; Erglis A; Morice MC; Mehran R; Van Mieghem NM; Nakamura S; De Benedictis M; Pavani M; Varbella F; Pisaniello M; Sharma SK; Tamburino C; Tchetche D; Colombo A;
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2401-2410. PubMed ID: 29217002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.